COVID-19 vaccine hesitancy in systemic sclerosis

Please use this identifier to cite or link to this item: https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/918

Full metadata record

DC Field	Value	Language
dc.contributor.author	Freeman, Daniel
dc.date.accessioned	2021-08-16T09:31:53Z
dc.date.available	2021-08-16T09:31:53Z
dc.date.issued	2021-07
dc.identifier.citation	J. Ciaffi, D. Giuggioli, A. Mari, M. D'onghia, A. Spinella, V. Brusi, L. Mancarella, L. Lisi, J. Faranda Cordella, D. Freeman, M.P. Landini, C. Ferri, R. Meliconi F. Ursini. COVID-19 vaccine hesitancy in systemic sclerosis. Exp Rheumatol . Jul-Aug 2021;39 Suppl 131(4):165-166. Epub 2021 Jul 15.	en
dc.identifier.uri	https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/918
dc.description.abstract	In conclusion, our survey suggests that most patients with SSc have positive feelings towards COVID-19 vaccine, but uncertainties are present in a considerable proportion of cases. These results highlight the crucial role of the caring rheumatologists in addressing concerns and hesitancy of individuals affected by rheumatic diseases with the purpose of promoting vaccine literacy and enhancing vaccination rates.	en
dc.description.sponsorship	Supported by the NIHR	en
dc.description.uri	https://www.clinexprheumatol.org/abstract.asp?a=17374	en
dc.language.iso	en	en
dc.subject	COVID-19	en
dc.subject	Vaccine Hesitancy	en
dc.subject	Sclerosis	en
dc.title	COVID-19 vaccine hesitancy in systemic sclerosis	en
dc.type	Article	en
Appears in Collections:	Musculoskeletal Diseases

Files in This Item:

There are no files associated with this item.

DSpace JSPUI